DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hofmeister CC, Chari A, Cohen Y. et al.
Daratumumab Monotherapy for Patients with Intermediate or High-Risk Smoldering Multiple Myeloma (SMM): Centaurus, a Randomized, Open-Label, Multicenter Phase 2 Study.
Blood 2017;
130: 510-510
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.